Orchard Therapeutics is a biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through autologous ex-vivo gene therapies. Founded in 2015, Orchard Therapeutics is based on research arising from the groups of Professor Bobby Gaspar and Professor Adrian Thrasher, at the UCL Institute of Child Health.